Mark Sabag
See "Remarks" · Teva Pharmaceutical Industries Ltd (TEVA)
sold: $3,902,274
| Date | Trade | Shares | Avg. price | Value | Filing |
|---|---|---|---|---|---|
| November 12, 2026 | Sale notice filed | 44,710 | $44.14 | $1,973,544 | SEC |
| November 5, 2026 | Sale | 46,000 | $41.93 | $1,928,729 | SEC |
Shown: open-market purchases and sales (Form 4, codes P and S) and notices of planned sales (Form 144), values as filed. Not shown: grants, tax withholding, gifts and option exercises — they are not trades. A disclosed trade does not show how the person rates the company and is not a recommendation.
